These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38633264)
21. Long-term effects of luteolin in a mouse model of nephropathic cystinosis. De Leo E; Taranta A; Raso R; Pezzullo M; Piccione M; Matteo V; Vitale A; Bellomo F; Goffredo BM; Diomedi Camassei F; Prencipe G; Rega LR; Emma F Biomed Pharmacother; 2024 Sep; 178():117236. PubMed ID: 39096619 [TBL] [Abstract][Full Text] [Related]
23. Cystinosis and two rare mutations in CTNS gene: two case reports. Gholami Yarahmadi S; Sarlaki F; Morovvati S J Med Case Rep; 2022 May; 16(1):181. PubMed ID: 35513889 [TBL] [Abstract][Full Text] [Related]
24. Time course of pathogenic and adaptation mechanisms in cystinotic mouse kidneys. Gaide Chevronnay HP; Janssens V; Van Der Smissen P; N'Kuli F; Nevo N; Guiot Y; Levtchenko E; Marbaix E; Pierreux CE; Cherqui S; Antignac C; Courtoy PJ J Am Soc Nephrol; 2014 Jun; 25(6):1256-69. PubMed ID: 24525030 [TBL] [Abstract][Full Text] [Related]
25. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Harrison F; Yeagy BA; Rocca CJ; Kohn DB; Salomon DR; Cherqui S Mol Ther; 2013 Feb; 21(2):433-44. PubMed ID: 23089735 [TBL] [Abstract][Full Text] [Related]
26. The gene therapy for corneal pathology with novel nonsense cystinosis mouse lines created by CRISPR Gene Editing. Dong F; Amlal H; Venkatakrishnan J; Zhang J; Fry M; Yuan Y; Cheng YC; Hu YC; Kao WW Ocul Surf; 2023 Jul; 29():432-443. PubMed ID: 37355021 [TBL] [Abstract][Full Text] [Related]
27. Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility. Ivanova EA; Arcolino FO; Elmonem MA; Rastaldi MP; Giardino L; Cornelissen EM; van den Heuvel LP; Levtchenko EN Kidney Int; 2016 May; 89(5):1037-1048. PubMed ID: 27083281 [TBL] [Abstract][Full Text] [Related]
28. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nevo N; Chol M; Bailleux A; Kalatzis V; Morisset L; Devuyst O; Gubler MC; Antignac C Nephrol Dial Transplant; 2010 Apr; 25(4):1059-66. PubMed ID: 19846395 [TBL] [Abstract][Full Text] [Related]
29. Quantitative in vivo and ex vivo confocal microscopy analysis of corneal cystine crystals in the Ctns knockout mouse. Simpson J; Nien CJ; Flynn K; Jester B; Cherqui S; Jester J Mol Vis; 2011; 17():2212-20. PubMed ID: 21897743 [TBL] [Abstract][Full Text] [Related]
30. Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis. Raggi C; Luciani A; Nevo N; Antignac C; Terryn S; Devuyst O Hum Mol Genet; 2014 May; 23(9):2266-78. PubMed ID: 24319100 [TBL] [Abstract][Full Text] [Related]
31. Cystinosis: a review. Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039 [TBL] [Abstract][Full Text] [Related]
38. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis. Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276 [TBL] [Abstract][Full Text] [Related]
39. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis. Kalatzis V; Serratrice N; Hippert C; Payet O; Arndt C; Cazevieille C; Maurice T; Hamel C; Malecaze F; Antignac C; Müller A; Kremer EJ Pediatr Res; 2007 Aug; 62(2):156-62. PubMed ID: 17597652 [TBL] [Abstract][Full Text] [Related]